Annual Net Margin
-16.24 K%
-13.51 K%-495.59%
31 December 2023
Summary:
Inovio Pharmaceuticals annual net profit margin is currently -16.24 thousand%, with the most recent change of -13.51 thousand% (-495.59%) on 31 December 2023. During the last 3 years, it has fallen by -13.99 thousand% (-623.25%). INO annual net margin is now -22474.19% below its all-time high of -71.94%, reached on 31 December 2015.INO Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Margin
N/A
30 September 2024
Summary:
Inovio Pharmaceuticals quarterly net profit margin is not available.INO Quarterly Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INO Net Margin Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -495.6% | - |
| 3 y3 years | -623.3% | - |
| 5 y5 years | -5004.9% | - |
INO Net Margin High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -623.3% | +5.1% | ||
| 5 y | 5 years | -5004.9% | +5.1% | ||
| alltime | all time | <-9999.0% | +5.1% |
Inovio Pharmaceuticals Net Margin History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | -31.99 K%(+31.3%) |
| Dec 2023 | -16.24 K%(+495.6%) | -24.36 K%(+178.9%) |
| Sept 2023 | - | -8734.77%(-44.5%) |
| June 2023 | - | -15.73 K%(-55.5%) |
| Mar 2023 | - | -35.36 K%(-19.1%) |
| Dec 2022 | -2726.67%(-84.1%) | -43.69 K%(>+9900.0%) |
| Sept 2022 | - | -412.75%(-97.0%) |
| June 2022 | - | -13.83 K%(-65.2%) |
| Mar 2022 | - | -39.72 K%(+211.7%) |
| Dec 2021 | -17.11 K%(+662.0%) | -12.75 K%(-38.2%) |
| Sept 2021 | - | -20.63 K%(-31.5%) |
| June 2021 | - | -30.11 K%(+105.4%) |
| Mar 2021 | - | -14.66 K%(+3261.1%) |
| Dec 2020 | -2245.39%(-22.6%) | -436.13%(-99.1%) |
| June 2020 | - | -48.17 K%(+1864.7%) |
| Mar 2020 | - | -2451.72%(-81.8%) |
| Dec 2019 | -2902.75%(+812.5%) | -13.48 K%(+405.9%) |
| Sept 2019 | - | -2663.71%(-87.7%) |
| June 2019 | - | -21.66 K%(+1997.8%) |
| Mar 2019 | - | -1032.52%(-21.6%) |
| Dec 2018 | -318.12%(+52.3%) | -1317.11%(+5.3%) |
| Sept 2018 | - | -1250.24%(+4503.2%) |
| June 2018 | - | -27.16%(-98.7%) |
| Mar 2018 | - | -2114.93%(+764.2%) |
| Dec 2017 | -208.92%(+0.2%) | -244.74%(-81.0%) |
| Sept 2017 | - | -1290.76%(+2679.4%) |
| June 2017 | - | -46.44%(-79.1%) |
| Mar 2017 | - | -222.49%(-27.8%) |
| Dec 2016 | -208.49%(+189.8%) | -308.12%(+86.1%) |
| Sept 2016 | - | -165.54%(-45.1%) |
| June 2016 | - | -301.50%(+204.0%) |
| Mar 2016 | - | -99.17%(-67.2%) |
| Dec 2015 | -71.94%(-79.2%) | -302.45%(-1407.6%) |
| Sept 2015 | - | 23.13%(-119.6%) |
| June 2015 | - | -118.19%(-42.3%) |
| Mar 2015 | - | -204.81%(-32.1%) |
| Dec 2014 | -345.44%(-29.5%) | -301.63%(-22.7%) |
| Sept 2014 | - | -390.01%(+38.4%) |
| June 2014 | - | -281.75%(-38.6%) |
| Mar 2014 | - | -458.99%(-48.3%) |
| Dec 2013 | -490.29%(+2.7%) | -888.35%(+172.9%) |
| Sept 2013 | - | -325.48%(-76.4%) |
| June 2013 | - | -1381.42%(+127.3%) |
| Mar 2013 | - | -607.75%(+946.9%) |
| Dec 2012 | -477.56%(+206.7%) | -58.05%(-92.5%) |
| Sept 2012 | - | -774.79%(-18.3%) |
| June 2012 | - | -947.80%(+94.4%) |
| Mar 2012 | - | -487.56%(+45.4%) |
| Dec 2011 | -155.72% | -335.42%(+94.8%) |
| Sept 2011 | - | -172.20%(+47.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2011 | - | -116.63%(+50.1%) |
| Mar 2011 | - | -77.69%(-70.9%) |
| Dec 2010 | -286.65%(+7.1%) | -266.68%(+141.4%) |
| Sept 2010 | - | -110.47%(-83.5%) |
| June 2010 | - | -671.14%(+301.9%) |
| Mar 2010 | - | -167.01%(-40.6%) |
| Dec 2009 | -267.67%(-56.7%) | -281.17%(+247.8%) |
| Sept 2009 | - | -80.85%(-81.1%) |
| June 2009 | - | -427.56%(-54.4%) |
| Mar 2009 | - | -937.74%(-14.3%) |
| Dec 2008 | -618.11%(+165.2%) | -1094.01%(+112.2%) |
| Sept 2008 | - | -515.55%(-15.0%) |
| June 2008 | - | -606.87%(+31.1%) |
| Mar 2008 | - | -462.73%(+1398.0%) |
| Dec 2007 | -233.05%(-34.5%) | -30.89%(-94.4%) |
| Sept 2007 | - | -553.84%(-26.7%) |
| June 2007 | - | -755.22%(-6.5%) |
| Mar 2007 | - | -807.86%(+280.4%) |
| Dec 2006 | -355.92%(+27.2%) | -212.35%(-64.1%) |
| Sept 2006 | - | -592.00%(+28.7%) |
| June 2006 | - | -460.06%(+21.9%) |
| Mar 2006 | - | -377.35%(+3.1%) |
| Dec 2005 | -279.79%(-70.2%) | -366.03%(-11.3%) |
| Sept 2005 | - | -412.82%(+471.8%) |
| June 2005 | - | -72.20%(-90.3%) |
| Mar 2005 | - | -742.24%(+6.2%) |
| Dec 2004 | -940.19%(-83.8%) | -699.13%(-7.3%) |
| Sept 2004 | - | -753.97%(-65.2%) |
| June 2004 | - | -2169.06%(-4.8%) |
| Mar 2004 | - | -2279.50%(-50.8%) |
| Dec 2003 | -5792.83%(+84.1%) | -4636.40%(-38.4%) |
| Sept 2003 | - | -7531.32%(-51.5%) |
| June 2003 | - | -15.52 K%(+650.8%) |
| Dec 2002 | -3147.32%(-45.2%) | -2066.86%(+0.9%) |
| Sept 2002 | - | -2048.85%(-45.4%) |
| June 2002 | - | -3752.18%(-88.8%) |
| Mar 2002 | - | -33.41 K%(>+9900.0%) |
| Dec 2001 | -5747.66%(+2681.8%) | - |
| Sept 2001 | - | -131.52%(-58.9%) |
| June 2001 | - | -320.18%(-44.0%) |
| Mar 2001 | - | -571.83%(+215.2%) |
| Mar 2001 | -206.62%(+9.3%) | - |
| Dec 2000 | - | -181.40%(+40.5%) |
| Sept 2000 | - | -129.09%(-69.8%) |
| June 2000 | - | -426.80%(+162.7%) |
| Mar 2000 | -189.07%(+138.4%) | -162.45%(-2.5%) |
| Dec 1999 | - | -166.67%(+11.4%) |
| Sept 1999 | - | -149.59%(-53.6%) |
| June 1999 | - | -322.22%(+584.3%) |
| Mar 1999 | -79.31% | -47.09% |
FAQ
- What is Inovio Pharmaceuticals annual net profit margin?
- What is the all time high annual net margin for Inovio Pharmaceuticals?
- What is Inovio Pharmaceuticals annual net margin year-on-year change?
- What is the all time high quarterly net margin for Inovio Pharmaceuticals?
What is Inovio Pharmaceuticals annual net profit margin?
The current annual net margin of INO is -16.24 K%
What is the all time high annual net margin for Inovio Pharmaceuticals?
Inovio Pharmaceuticals all-time high annual net profit margin is -71.94%
What is Inovio Pharmaceuticals annual net margin year-on-year change?
Over the past year, INO annual net profit margin has changed by -13.51 K% (-495.59%)
What is the all time high quarterly net margin for Inovio Pharmaceuticals?
Inovio Pharmaceuticals all-time high quarterly net profit margin is 23.13%